Serial entrepreneur and operator focused on growth-stage technology companies, with experience building go-to-market teams, product-led growth, and scaling SaaS and marketplace models. Byron Gustus combines founder experience with angel and seed investing, serving on several private company boards and advising venture-backed management teams. Market-relevant strengths include revenue scaling, customer acquisition strategy, capital raises and exit preparation for strategic or acquisition outcomes.
Serial entrepreneur and operator focused on growth-stage technology companies, with experience building go-to-market teams, product-led growth, and scaling SaaS and marketplace models. Byron Gustus combines founder experience with angel and seed investing, serving on several private company boards and advising venture-backed management teams. Market-relevant strengths include revenue scaling, customer acquisition strategy, capital raises and exit preparation for strategic or acquisition outcomes.
Combines founder-operator sensibilities with pragmatic early-stage investing, prioritizing growth-stage tech companies where product-led distribution and repeatable SaaS or marketplace unit economics are emerging. Focuses on capital-efficient revenue scaling, go-to-market motion optimization, and customer acquisition channels that demonstrate scalable CAC payback. Prefers lead or active seed/angel positions that allow board or adviser proximity to influence hiring, metrics discipline, and fundraising cadence. Investment horizon spans 3–7 years with exit-oriented playbooks; risk managed through concentration in core sectors, hands-on operational support, milestone-based follow-ons, and disciplined cap allocation tied to growth inflection points.
Combines founder-operator sensibilities with pragmatic early-stage investing, prioritizing growth-stage tech companies where product-led distribution and repeatable SaaS or marketplace unit economics are emerging. Focuses on capital-efficient revenue scaling, go-to-market motion optimization, and customer acquisition channels that demonstrate scalable CAC payback. Prefers lead or active seed/angel positions that allow board or adviser proximity to influence hiring, metrics discipline, and fundraising cadence. Investment horizon spans 3–7 years with exit-oriented playbooks; risk managed through concentration in core sectors, hands-on operational support, milestone-based follow-ons, and disciplined cap allocation tied to growth inflection points.
| Trades 790 | Longs Won 550/790 69% | Profit Factor 9.64 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $456,483.94 |
| Average Win $141,483.54 | Best Trade (Oct 14) $9.24M | Sharpe Ratio -13.29 |
| Average Loss -$33,625.59 | Worst Trade (Oct 16) -$1.03M | Z-Score 14.17 (100%) |
| Commissions $0 | Avg. Trade Length 10m | Expectancy $88,290.16 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,897 | 6,207 | 5,517 | 4,828 | 4,138 | 3,448 | 2,759 | 2,069 | 1,379 | 690 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 19,752 | $5.04M | $6.82M | - | $1.78M | 35.29% | +0.901% |
ABBV AbbVie Inc. | 13,222 | $2.58M | $3.77M | - | $1.19M | 46.3% | +0.723% |
AEP American Electric Power Company, Inc. | 3,047 | $334,792.38 | $384,830.92 | - | $50,038.54 | 14.95% | +1.616% |
AGNCO AGNC Investment Corp. 10.1219% Perpetual Preferred Stock | 101,142 | $2.56M | $2.55M | - | -$11,569.04 | -0.45% | +0.239% |
AIQ Global X Artificial Intelligence & Technology ETF | 7,089 | $373,224.65 | $448,521.03 | - | $75,296.38 | 20.17% | -1.279% |
ALL Allstate Corporation | 4,992 | $964,909.33 | $1.21M | - | $245,251.31 | 25.42% | +1.177% |
AMAT Applied Materials, Inc. | 530 | $383,190 | $223,951.5 | - | -$159,238.5 | -41.56% | -1.735% |
AMD Advanced Micro Devices, Inc. | 4,091 | $743,372.35 | $2.23M | - | $1.49M | 200.2% | -2.976% |
AMGN Amgen Inc. | 4,743 | $1.34M | $2.07M | - | $728,542.39 | 54.34% | +0.514% |
AMZN Amazon.com Inc | 12,996 | $2.86M | $3.3M | - | $430,549.14 | 15.03% | -0.471% |
ANET Arista Networks, Inc. | 18,523 | $2.22M | $3.38M | - | $1.17M | 52.73% | -1.579% |
APLD Applied Digital Corporation | 8,967 | $216,131 | $176,022.21 | - | -$40,108.79 | -18.56% | -3.727% |
ARCC Ares Capital Corporation | 171,613 | $3.67M | $3.25M | - | -$421,121.71 | -11.47% | +0.132% |
ASML ASML Holding N.V. New York Registry Shares | 928 | $990,224.6 | $1.56M | - | $568,546.28 | 57.42% | +1.344% |
AVGO Broadcom Inc. | 31,375 | $7.83M | $10.6M | - | $2.77M | 35.37% | -1.849% |
BAC Bank of America Corporation | 68,933 | $3.13M | $3.6M | - | $472,355.71 | 15.09% | +1.064% |
BG Bunge Global S.A. | 2,260 | $285,936.76 | $243,243.8 | - | -$42,692.96 | -14.93% | +0.579% |
BHLB Berkshire Hills Bancorp Inc | 7,574 | $227,319.48 | $227,213.81 | - | -$105.67 | -0.05% | -1.483% |
BKR Baker Hughes Company | 6,391 | $375,663.2 | $355,723.06 | - | -$19,940.14 | -5.31% | +2.316% |
BMY Bristol-Myers Squibb Company | 19,000 | $1.08M | $1.15M | - | $75,835.44 | 7.04% | +0.223% |